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Complications associated with the Angio-Seal
arterial puncture closing device: Intra-arterial
deployment and occlusion by dissected plaque
Einar Dregelid, MD,a Guttorm Jensen, MD,b and Alireza Daryapeyma, MD,a Bergen, Norway
The Angio-Seal arterial closure device is widely used to prevent bleeding and facilitate early ambulation after arterial
puncture. We had referred to us three female patients in whom this device had been used; its sponge had been
unintentionally deployed in the arterial lumen. In a fourth female patient, a dissected plaque underneath the device
occluded the femoral artery. Severe lower extremity ischemia occurred in each case. One intraluminal sponge was detected
only after 20 days, when the patient had developed severe symptoms due to microembolization; in another patient,
ischemia occurred 9 days after intraluminal deployment. In two, or possibly three, of the cases, the superficial femoral
artery had been punctured. The device should not be used when the superficial femoral artery has been punctured, in
which case complications are more likely to occur. Lower limb ischemia within several months after deployment of these
devices should be investigated with duplex ultrasound scanning to examine the possibility that the ischemiamay be caused
by the device or by device-related thrombus. It is important to register the use of such devices in the procedural reports
to make it possible to link their use to eventual later ischemic events. ( J Vasc Surg 2006;44:1357-9.)Although meta-analyses have failed to show any advan-
tage of arterial puncture closing devices compared with
mechanical compression and despite their higher costs,
they are increasingly being used to prevent bleeding and
facilitate early ambulation after arterial puncture.1-3 The
Angio-Seal (St JudeMedical, St Paul,Minn) arterial closure
device, composed of an absorbable collagen sponge and an
absorbable suture and anchor and intended for closure of
puncture holes in normal arteries, has shown a trend toward
performing better than other devices and having fewer
complications than manual compression in a percutaneous
coronary intervention (PCI) setting.3 During a 6-month
period, at our hospital we treated three patients in whom
this device had been used and in whom its sponge compo-
nent had unintentionally been deployed in the arterial
lumen. In a fourth patient, a dissected plaque underneath
the device occluded the artery. All devices, three 6F and
one 8F, were deployed by experienced interventionists;
three were cardiologists, and one was radiologist. All de-
vices were appropriate for the size of sheath used for
vascular access. A femoral angiogram was performed before
deployment of the Angio-Seal in case 2 only.
CASE REPORTS
Case 1. An 85-year-old woman underwent a PCI for the
second time within 3 months because of unstable angina and
three-vessel disease. Nine days after the PCI procedure, her left leg
turned pale, cold, and painful, and sensibility was reduced. Pulses
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doi:10.1016/j.jvs.2006.07.034in the left groin were weak, and there were no audible Doppler
signals at the left ankle. Acute embolization was suspected, and she
was operated on under general anesthesia. There was a pro-
nounced fibrotic reaction surrounding the groin vessels secondary
to a hematoma after the PCI. An Angio-Seal suture was seen to
protrude from a sealed puncture hole in the superficial femoral
artery (SFA). In this patient, the division of the common femoral
artery was located uncommonly proximally, perhaps explaining
why the puncture site was in the SFA rather than in the common
femoral artery. Upon opening the SFA, the Angio-Seal sponge
with attached thrombus was found to totally occlude the SFA. The
Angio-Seal sponge with adjacent thrombi was removed from the
artery, which was then closed with a polyester urethane patch
(Vascular-patch, B. Braun Medical AG, Tuttlingen, Germany) to
avoid narrowing. The artery reoccluded 2 days later because of a
dissected intima. The patient underwent successful reoperation
with thromboendarterectomy 6 days after the first operation. At
1-month follow-up, she was well and had no claudication.
Case 2. A 60-year-old woman with intermittent claudication
after walking 20 m and bilateral iliac arterial stenoses underwent
bilateral iliac artery percutaneous angioplasty and stenting. An
Angio-Seal device was used for arterial closure in the left groin.
Immediately after the procedure, she developed ischemic pain in
the left leg. Pulses could be palpated in the groin but not further
distally on the left side. She was given fluid and low-molecular-
weight heparin. Duplex ultrasound scanning (DUS) showed a
nearly occlusive mass with a suture-like tail in the proximal SFA.
The tail projected out through the arterial wall. The finding was
suggestive of a dislodged Angio-Seal device. She was operated
on under local anesthesia. The Angio-Seal device was located in
the proximal part of the SFA. It was removed through a longitu-
dinal arteriotomy placed directly over it. The patient later needed
additional bilateral stenting in the common iliac arteries because of
dissection at the distal ends of the first iliac stents. Onemonth later,
the ankle-brachial pressure index was 1.0 bilaterally, and the pa-
tient had no symptoms of claudication.
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to coronary artery disease and a history of smoking underwent
coronary angiography after an episode of chest pain. An Angio-Seal
device was used for arterial closure. Immediately after leaving the
angio suite, there were signs of ischemia in the right leg, which
became pale and painful. The acute ischemia ameliorated after
approximately an hour. DUS by an experienced cardiologist
showed triphasic flow and normal color filling from the aortic
bifurcation to the proximal leg arteries on the right side. In the
following weeks, the patient developed right leg claudication after
walking 200 m and had frostbite-like pain in the toes and sole of
the right foot. Nineteen days after the angiography, she was
admitted to our hospital with intense rest pain in the toes and sole
of the right foot. The fifth toe was slightly cyanotic. On the
following day, there was found to be normal capillary refilling in
both feet and palpable pulses in the right dorsalis pedis and
posterior tibial arteries. Duplex examination of the arteries from
aortic bifurcation to crural arteries showed a mass in the right
common femoral artery with a suture-like tail projecting into the
SFA (Fig 1). There was intense tenderness of the sole of the foot
and the toes on the right side. The acute pain was ascribed to
microembolization. She was given aspirin and low-molecular-
weight heparin, and the next day the pain in the right foot was
markedly reduced. The mass, an Angio-Seal sponge with suture,
was removed through a small arteriotomy on the common femoral
artery under local anesthesia (Fig 2).
Case 4. An 84-year-old woman underwent coronary angiog-
raphy for suspected myocardial infarction through the right groin.
When three-vessel disease was found, PCI was first considered not
Fig 1. In case 3, the Angio-Seal device was located in the distal
common femoral artery with the resorbable suture (arrow) pro-
jecting into the superficial femoral artery. The distance marked on
the figure is 0.53 cm and represents the width of the Angio-Seal
sponge.indicated, and an Angio-Seal device was deployed. After discus-sion, PCI was after all found to be indicated and was performed
through the left groin. Immediately afterward, the right leg be-
came cold and painful, and low-molecular-weight heparin was
administered, whereafter the ischemia improved somewhat. The
next day, the right ankle-brachial Doppler pressure index was 0.14.
There were no pulses in the popliteal artery, and DUS showed
occlusion of the right common femoral artery. The patient was
subsequently operated on under local anesthesia. An Angio-Seal
sponge was found on the wall of the common femoral artery, with
the intima immediately underneath dissected off the wall, causing
arterial occlusion. The sponge and dissected intima were removed.
After surgery, she had no more pain in the right leg, where the
circulation was clinically normalized. Apart from a wound hema-
toma that resolved spontaneously and slightly reduced sensitivity
in the medial part of the right foot, the further course was unevent-
ful.
DISCUSSION
One important finding in this study is that an intralu-
minally deployed Angio-Seal device may be overlooked and
remain undetected despite DUS when the remaining lu-
men is of sufficient size to allow adequate flow. In case 3,
the intraluminally deployed device may have been mistaken
for a plaque at the initial DUS. Only the resorbable suture
is of telltale diagnostic importance. If the suture is missed
on examination, the diagnosis of a misplaced hemostatic
device may be overlooked. The intraluminally placed device
was detected only when the patient developed severe symp-
toms 19 days later because of microembolization. Symp-
toms that occur later because of microembolization from
device-associated thrombi or because of embolization of
the device itself or its components may not always be
ascribed to the device. It is therefore important to record
the use of Angio-Seal in the procedural report to make it
possible to link its use to eventual later ischemic events.
All four of our patients were women. Other studies
have shown that odds for severe access complications sec-
Fig 2. Angio-Seal with thrombus and intima from case 3 after
fixation in formaldehyde. A fragment of the resorbable suture is
seen in the right lower corner.ondary to the use of collagen-based vascular closure devices
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This is thought to be related to smaller arterial diameters
in women.4 Presumably, intraluminally placed Angio-Seal
sponges lead to more severe stenosis in thin female arteries
than in larger male ones, although large vessel size does not
preclude total occlusion if any collagen is inside the lumen.
Another possible explanation as to why complications,
including intra-arterial deployment, are seen more fre-
quently in women could be that the 10-mm-long anchor of
the device may be more likely to be caught by a plaque
when it is being retracted toward the wall in arteries with
smaller luminal diameters.5 This, in our opinion, was the
most likely mechanism causing dissection in case 4. Prede-
ployment DUS might therefore be recommended to re-
duce complication rates selectively in women.
The four patients who had an Angio-Seal sponge re-
moved from their arteries during the 6-month period trans-
late to an incidence of approximately 1 per 275 devices on
the basis of the number of devices used during 2005. In
another study, 1 artery occlusion due to an Angio-Seal
device deployed inside an artery was found after 220 de-
ployments in 186 patients.8 In yet another study, acute
femoral artery occlusion related to the use of the Angio-
Seal device occurred in 5 of 742 deployments.9 Femoral
angiography was, however, not recommended by the pro-
ducer and was not routinely performed at that time. For
comparison, acute occlusions have been found in less than
0.2% using compression techniques for sheath removal.5,10
The suture fractured easily when the Angio-Seal was
removed from the artery in case 3, 20 days after implanta-
tion. It is therefore conceivable that the suture or anchor
may break off and embolize after several weeks when the
degradation has weakened the resorbable suture material
sufficiently.
Although it may be practically impossible to link the
cause of newly developed lower limb ischemia to the im-
plantation of an intra-arterial hemostatic device several
weeks earlier, such a case has been reported by Shaw et al.11
In their report, ischemic symptoms occurred 3months after
implantation. An eccentric, almost occluding, lesion in the
femoral artery dislodged to the popliteal artery during
attempted balloon angioplasty. Themass was interpreted as
being the anchor of the device. The mass was, however, big
enough to totally occlude the popliteal artery and was
similar in appearance and size to the sponges removed from
our cases. Therefore, in our opinion, it most likely repre-
sented an intravascularly deployed Angio-Seal sponge.In conclusion, as illustrated by our case 3, intra-arterial
sponge deployment may remain undetected, and ischemic
symptoms may occur several weeks after intra-arterial de-
ployment of the Angio-Seal device. Every instance of lower
limb ischemia within several months after deployment of
such devices should be investigated with duplex ultra-
sonography to exclude the possibility that the ischemia may
be caused by the device or by a device-related thrombus.
Fluoroscopy is recommended to ensure that the puncture
site is in the common femoral artery. If the SFA has been
punctured, it is not advisable to use the device.
We are indebted to Torbjorn Jonung, MD, PhD, for
providing case 4.
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